Headlands Technologies LLC made a new investment in Thermo Fisher Scientific, while M&G Plc purchased a significant number of shares. Biotech company CytoReason secured $80 million funding from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific and plans to establish a US hub in Cambridge. Several firms have demonstrated a trend of buying and selling Thermo Fisher Shares, including CFO4Life Group LLC and Thoroughbred Financial Services. The company's shares have outperformed market returns, with investors making a CAGR of 17% over the past five years. The company has announced quarterly dividends and has completed the acquisition of Olink. For the earnings quarter, Thermo Fisher Scientific reported a strong financial outlook with an adjusted EPS exceeding analysts' expectations. The company's analysis shows resilience despite economic challenges. A warning about the demand for 2024 was issued, but this has been attributed to caution rather than fundamental weakness. The company's plans also include the presentation at BofA Securities 2024 Health Care Conference in May and the introduction of an innovative mass spectrometer to advance clinical research.
Thermo Fisher Scientific TMO News Analytics from Tue, 17 Oct 2023 07:00:00 GMT to Sun, 21 Jul 2024 20:15:07 GMT -
Rating 8
- Innovation 8
- Information 7
- Rumor 3
